Cancer Treatment
OwnerJames Berger Camdeninventor
Life of this patent
Estimating the term…
Abstract
This invention is a method of treating cancer, including carcinomas and sarcomas through the administration of a pharmaceutical composition containing a imidazole-1,2-diamine derivative. The imidazole-1,2-diamine derivative is selected from the group consisting of: 1 wherein Y and X are independently selected from the group consisting of hydrogen, halogen, e.g., chloro, fluoro, nitro, methyl, ethyl, oxychloro or alkoxy of less than 7 carbon atoms; n is a positive integer of less than 5; R1 and R2 are independently selected form the group consisting of hydrogen and the pharmaceutically acceptable salts and prodrugs thereof.
Claims42
A method of treating cancer comprising administering to a patient in need thereof a therapeutically effective amount of a composition comprising a imidazole-1,2-diamine compound selected from the group consisting of:
- 8
- wherein Y and X are independently selected from the group consisting of hydrogen, halogen, nitro, methyl, ethyl, oxychloro or alkoxy of less than 7 carbon atoms;
- n is a positive integer of less than 5;
- R1 and R2 are independently selected from the group consisting of hydrogen and the pharmaceutically acceptable salts and prodrugs thereof.
A pharmaceutical composition comprising a therapeutically effective amount of a composition comprising a imidazole-1,2-diamine compound selected from the group consisting of:
- 10
- wherein Y and X are independently selected from the group consisting of hydrogen, halogen, nitro, methyl, ethyl, oxychloro or alkoxy of less than 7 carbon atoms;
- n is a positive integer of less than 5;
- R1 and R2 are independently selected form the group consisting of hydrogen and the pharmaceutically acceptable salts and prodrugs thereof.
A method of treating cancer comprising administering to a patient in need thereof a therapeutically effective amount of a combination therapy comprising a imidazole-1,2-diamine compound selected from the group consisting of:
- 11
- wherein Y and X are independently selected from the group consisting of hydrogen, halogen, nitro, methyl, ethyl, oxychloro or alkoxy of less than 7 carbon atoms;
- n is a positive integer of less than 5;
- R1 and R2 are independently selected from the group consisting of hydrogen and the pharmaceutically acceptable salts and prodrugs thereof, and a safe and effective amount of a chemotherapeutic agent.
A liposome composition comprising a imidazole-1,2-diamine compound selected from the group consisting of:
- 13
- wherein Y and X are independently selected from the group consisting of hydrogen, halogen, nitro, methyl, ethyl, oxychloro or alkoxy of less than 7 carbon atoms;
- n is a positive integer of less than 5;
- R1 and R2 are independently selected form the group consisting of hydrogen and the pharmaceutically acceptable salts and prodrugs thereof.
A pharmaceutical composition comprising the hydrochloride salt of a imidazole-1,2-diamine compound having the structure:
- 14
Dependencies are inferred from the claim text.